Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial (vol 11, pg 611, 2009)

被引：0
|
作者：
Jadzinsky, M.
Pfuetzner, A.
Paz-Pacheco, F.
Xu, Z.
Allen, F.
Chen, R.
机构：
来源：
DIABETES OBESITY & METABOLISM | 2010年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [21] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [22] Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Garber, A.
    DIABETES OBESITY & METABOLISM, 2008, 10 (05): : 436 - 437
  • [23] Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study
    Garber, A. J.
    Schweizer, A.
    Baron, M. A.
    Rochotte, E.
    Dejager, S.
    DIABETES OBESITY & METABOLISM, 2007, 9 (02): : 166 - 174
  • [24] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [25] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [26] Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    DIABETES CARE, 2019, 42 (08) : 1464 - 1472
  • [27] Efficacy and safety of saxagliptin and metformin as initial combination therapy in patients with type 2 diabetes: a meta-analysis
    Tan, Xue-Ying
    Lu, Yang
    Xuan, Li-Ping
    Huang, Yong-Min
    Hu, Jing-Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 18816 - 18823
  • [28] Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin (vol 18, pg 463, 2016)
    Pettus, J.
    McNabb, B.
    Eckel, R. H.
    Skyler, J. S.
    Dhalla, A.
    Guan, S.
    Jochelson, P.
    Belardinelli, L.
    Henry, R. H.
    DIABETES OBESITY & METABOLISM, 2018, 20 (07): : 1805 - 1805
  • [29] Ertugliflozin effectively improves glycaemic control as monotherapy in patients with type 2 diabetes: the VERTIS MONO trial
    Terra, S.
    Davies, M. J.
    Frias, J.
    Derosa, G.
    Darekar, A.
    Focht, K.
    Golm, G.
    Johnson, J.
    Saur, D.
    Dagogo-Jack, S.
    DIABETOLOGIA, 2016, 59 : S346 - S346
  • [30] Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Pokharna, H.
    Kanna, B.
    DIABETES OBESITY & METABOLISM, 2007, 9 (06): : 914 - 914
12345